Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets

BACKGROUND: PCSK9 (Proprotein Convertase Subtilisin Kexin type 9) is a circulating protein that promotes hypercholesterolemia by decreasing hepatic LDL receptor protein. Under non interventional conditions, its expression is driven by sterol response element binding protein 2 (SREBP2) and follows a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cariou, Bertrand, Langhi, Cédric, Le Bras, Maëlle, Bortolotti, Murielle, Lê, Kim-Anne, Theytaz, Fanny, Le May, Cédric, Guyomarc’h-Delasalle, Béatrice, Zaïr, Yassine, Kreis, Roland, Boesch, Chris, Krempf, Michel, Tappy, Luc, Costet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548771/
https://www.ncbi.nlm.nih.gov/pubmed/23298392
http://dx.doi.org/10.1186/1743-7075-10-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548771/
https://www.ncbi.nlm.nih.gov/pubmed/23298392
http://dx.doi.org/10.1186/1743-7075-10-4

Ejemplares similares